$510,000 of EMERGENT BIOSOLUTIONS INC lobbying was just disclosed, from Q2 of 2026, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"- Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 Tribal Opioid Response Grant funding for FY27 H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD) - Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD) - Reauthorization of Protecting Americans from All-Hazards Preparedness Act - Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 - Opioid crisis legislation, naloxone access and awareness - State opioid response (SOR) Grant funding FY27 - Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 - Tribal Opioid Response Grant funding for FY27 - H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone - H.R. 5252, Having Overdoes Protection Equipment Act - Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD) Reauthorization of Protecting Americans from All-Hazards Preparedness Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY27 Opioid crisis legislation, naloxone access and awareness State opioid response (SOR) Grant funding FY27 Substance Use Prevention, Treatment and Recovery Service Block Grant funding for FY27 Tribal Opioid Response Grant funding for FY27 H.R. 8800/S. 4784 - NDAA for Fiscal Year 2027 - provisions related to biological and chemical defense and access to naloxone H.R. 5252, Having Overdoes Protection Equipment Act Reauthorization of the surface transportation program last included in the Infrastructure Investments and Jobs Act (H.R. 8870, S. TBD)"
You can find more data on corporate lobbying on Quiver Quantitative.
EBS Insider Trading Activity
EBS insiders have traded $EBS stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $EBS stock by insiders over the last 6 months:
- KATHRYN C ZOON has made 0 purchases and 2 sales selling 17,202 shares for an estimated $144,453.
- DONALD W DEGOLYER has made 0 purchases and 2 sales selling 15,481 shares for an estimated $129,993.
- KEITH KATKIN sold 15,481 shares for an estimated $128,182
- SUJATA TYAGI DAYAL has made 0 purchases and 2 sales selling 13,761 shares for an estimated $115,610.
- PAUL ANTHONY WILLIAMS (SVP, Products Business) has made 0 purchases and 2 sales selling 7,000 shares for an estimated $58,960.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
EBS Hedge Fund Activity
We have seen 92 institutional investors add shares of EBS stock to their portfolio, and 66 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- OAK HILL ADVISORS LP removed 2,500,000 shares (-69.2%) from their portfolio in Q1 2026, for an estimated $20,750,000
- JAIN GLOBAL LLC removed 743,707 shares (-78.9%) from their portfolio in Q1 2026, for an estimated $6,172,768
- PROSIGHT MANAGEMENT, LP added 639,118 shares (+inf%) to their portfolio in Q1 2026, for an estimated $5,304,679
- AQR CAPITAL MANAGEMENT LLC added 511,648 shares (+107.0%) to their portfolio in Q1 2026, for an estimated $4,246,678
- DIMENSIONAL FUND ADVISORS LP added 504,553 shares (+22.4%) to their portfolio in Q1 2026, for an estimated $4,187,789
- MORGAN STANLEY removed 413,160 shares (-35.7%) from their portfolio in Q1 2026, for an estimated $3,429,228
- PRUDENTIAL FINANCIAL INC added 358,880 shares (+399.0%) to their portfolio in Q1 2026, for an estimated $2,978,704
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
